YIFAN PHARMACEUTICAL(SZ:002019) Zheng Quan Zhi Xing·2025-09-05 16:33Core Viewpoint - The legal opinion letter from Anhui Tianhe Law Firm confirms that the procedures for the second extraordinary general meeting of Yifan Pharmaceutical Co., Ltd. in 2025 comply with relevant laws and regulations, and the voting results are valid and legal [1][16]. Group 1: Meeting Procedures - The board of directors approved the proposal to convene the second extraordinary general meeting on August 13, 2025 [1]. - The notice for the meeting was published on August 15, 2025, in compliance with the 15-day prior notice requirement [2]. - The meeting will include both on-site and online voting, with specific time slots for each [2]. - The on-site meeting is scheduled for September 5, 2025, at a designated location in Hefei, Anhui Province [2]. Group 2: Attendance and Voting - A total of 305 shareholders and representatives attended the meeting, representing 523,447,918 shares, which is 43.0329% of the total voting shares [3]. - Of the attendees, 8 were present on-site, representing 499,217,507 shares (41.0409%), while 297 participated via online voting, representing 24,230,411 shares (1.9920%) [3]. - The qualifications of all attendees, including shareholders, representatives, and company executives, were verified and deemed compliant with legal requirements [3]. Group 3: Voting Results - The meeting reviewed and voted on several proposals, all of which were consistent with the previously announced agenda [4]. - The voting process combined on-site and online methods, with results announced immediately after the voting period [4]. - The first proposal received 523,132,518 votes in favor, accounting for 99.9397% of the valid votes cast [4]. - The voting results for small investors showed 23,927,011 votes in favor, representing 98.6990% of their valid votes [5]. - Other proposals, including amendments to various internal regulations, also received overwhelming support, with approval rates generally above 98% [6][10][12].